Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001372514-25-000078
Filing Date
2025-11-07
Accepted
2025-11-07 06:01:36
Documents
81
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kprx-20250930.htm   iXBRL 10-Q 1230056
2 EX-31.1 kprx-20250930xexx311.htm EX-31.1 7435
3 EX-31.2 kprx-20250930xexx312.htm EX-31.2 7431
4 EX-32.1 kprx-20250930xexx321.htm EX-32.1 3847
5 EX-32.2 kprx-20250930xexx322.htm EX-32.2 3832
11 KIORA LOGO kprx-20250930_g1.jpg GRAPHIC 348944
  Complete submission text file 0001372514-25-000078.txt   8615324

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kprx-20250930.xsd EX-101.SCH 55467
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kprx-20250930_cal.xml EX-101.CAL 76241
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kprx-20250930_def.xml EX-101.DEF 250822
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kprx-20250930_lab.xml EX-101.LAB 727850
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kprx-20250930_pre.xml EX-101.PRE 500408
84 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20250930_htm.xml XML 1136597
Mailing Address 169 SAXONY RD. SUITE 212 ENCINITAS CA 92024
Business Address 169 SAXONY RD. SUITE 212 ENCINITAS CA 92024 858-224-9600
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

EIN.: 980443284 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 251460250
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)